je.st
news
BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
2013-12-25 08:45:04| Biotech - Topix.net
In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock.
Tags: balance
sheet
enhancement
pharmaceuticals
Category:Biotechnology and Pharmaceuticals